Cambridge starts new drug trial to help alleviate symptoms of long covid - "HEAL-Covid"

[kiwibird]

https://www.universitynewshq.com/un...eaths-after-covid-19-patients-leave-hospital/

HEAL-COVID stands for Helping to Alleviate the Longer-term consequences of COVID-19 and is funded by the National Institute for Health Research (NIHR) and the NIHR Cambridge Biomedical Research Centre. It will test a number of safe, existing drugs on patients across the UK in order to find effective treatments.

Study lead Dr Charlotte Summers, from the University of Cambridge and Addenbrooke?s Hospital, said: ?Having survived the trauma of being hospitalised with COVID-19, far too many patients find themselves back in hospital with new or long term complications.

?Unfortunately, many go on to die in the months after being discharged. This trial is the first of its kind to look at what drugs we could use to reduce the devastating impact on patients.?

The trial is being led by Cambridge University Hospitals NHS Foundation Trust and University of Cambridge, in collaboration with Liverpool Clinical Trials Centre at the University of Liverpool, and Aparito Limited.

HEAL-COVID will enrol patients when they are discharged from hospital, following their first admission for COVID-19. They will be randomised and given one of two drugs ? apixaban and atorvastatin ? and their progress tracked. It?s hoped a third drug will be introduced to the trial on the recommendation of the UK COVID Therapeutic Advisory Panel in the coming weeks.

 

[sharon sanders]

bump this